Mifepristone (RU-486) in Androgen Independent Prostate Cancer

NCT00140478 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Adenocarcinoma of Prostate

Interventions

DRUG: Mifepristone

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]